Pharma & Healthcare
Global Oral Live Cholera Vaccines Market Research Report 2025
- Sep 09, 25
- ID: 497267
- Pages: 81
- Figures: 84
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Live Cholera Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Live Cholera Vaccines.
The Oral Live Cholera Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Live Cholera Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Live Cholera Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Segment by Type
Euvichol- Plus
DUKORAL
Shanchol
Others
Segment by Application
Prevention
Emergency Response
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Live Cholera Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Oral Live Cholera Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Live Cholera Vaccines.
The Oral Live Cholera Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Live Cholera Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Live Cholera Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Segment by Type
Euvichol- Plus
DUKORAL
Shanchol
Others
Segment by Application
Prevention
Emergency Response
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Live Cholera Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Oral Live Cholera Vaccines Market Overview
1.1 Product Definition
1.2 Oral Live Cholera Vaccines by Type
1.2.1 Global Oral Live Cholera Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Euvichol- Plus
1.2.3 DUKORAL
1.2.4 Shanchol
1.2.5 Others
1.3 Oral Live Cholera Vaccines by Application
1.3.1 Global Oral Live Cholera Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Prevention
1.3.3 Emergency Response
1.4 Global Oral Live Cholera Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Live Cholera Vaccines Revenue 2020-2031
1.4.2 Global Oral Live Cholera Vaccines Sales 2020-2031
1.4.3 Global Oral Live Cholera Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oral Live Cholera Vaccines Market Competition by Manufacturers
2.1 Global Oral Live Cholera Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oral Live Cholera Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oral Live Cholera Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oral Live Cholera Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Live Cholera Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Live Cholera Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Oral Live Cholera Vaccines, Date of Enter into This Industry
2.8 Global Oral Live Cholera Vaccines Market Competitive Situation and Trends
2.8.1 Global Oral Live Cholera Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Live Cholera Vaccines Players Market Share by Revenue
2.8.3 Global Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Live Cholera Vaccines Market Scenario by Region
3.1 Global Oral Live Cholera Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oral Live Cholera Vaccines Sales by Region: 2020-2031
3.2.1 Global Oral Live Cholera Vaccines Sales by Region: 2020-2025
3.2.2 Global Oral Live Cholera Vaccines Sales by Region: 2026-2031
3.3 Global Oral Live Cholera Vaccines Revenue by Region: 2020-2031
3.3.1 Global Oral Live Cholera Vaccines Revenue by Region: 2020-2025
3.3.2 Global Oral Live Cholera Vaccines Revenue by Region: 2026-2031
3.4 North America Oral Live Cholera Vaccines Market Facts & Figures by Country
3.4.1 North America Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.4.3 North America Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Oral Live Cholera Vaccines Market Facts & Figures by Country
3.5.1 Europe Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.5.3 Europe Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Live Cholera Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Live Cholera Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oral Live Cholera Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Live Cholera Vaccines Market Facts & Figures by Country
3.7.1 Latin America Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Live Cholera Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Live Cholera Vaccines Sales by Type (2020-2031)
4.1.1 Global Oral Live Cholera Vaccines Sales by Type (2020-2025)
4.1.2 Global Oral Live Cholera Vaccines Sales by Type (2026-2031)
4.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Oral Live Cholera Vaccines Revenue by Type (2020-2031)
4.2.1 Global Oral Live Cholera Vaccines Revenue by Type (2020-2025)
4.2.2 Global Oral Live Cholera Vaccines Revenue by Type (2026-2031)
4.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Oral Live Cholera Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oral Live Cholera Vaccines Sales by Application (2020-2031)
5.1.1 Global Oral Live Cholera Vaccines Sales by Application (2020-2025)
5.1.2 Global Oral Live Cholera Vaccines Sales by Application (2026-2031)
5.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Oral Live Cholera Vaccines Revenue by Application (2020-2031)
5.2.1 Global Oral Live Cholera Vaccines Revenue by Application (2020-2025)
5.2.2 Global Oral Live Cholera Vaccines Revenue by Application (2026-2031)
5.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Oral Live Cholera Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PaxVax
6.1.1 PaxVax Company Information
6.1.2 PaxVax Description and Business Overview
6.1.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PaxVax Oral Live Cholera Vaccines Product Portfolio
6.1.5 PaxVax Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Oral Live Cholera Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Valneva
6.3.1 Valneva Company Information
6.3.2 Valneva Description and Business Overview
6.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Valneva Oral Live Cholera Vaccines Product Portfolio
6.3.5 Valneva Recent Developments/Updates
6.4 EuBiologics
6.4.1 EuBiologics Company Information
6.4.2 EuBiologics Description and Business Overview
6.4.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 EuBiologics Oral Live Cholera Vaccines Product Portfolio
6.4.5 EuBiologics Recent Developments/Updates
6.5 Shanghai United Cell Biotechnology
6.5.1 Shanghai United Cell Biotechnology Company Information
6.5.2 Shanghai United Cell Biotechnology Description and Business Overview
6.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolio
6.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
6.6 Vabiotech
6.6.1 Vabiotech Company Information
6.6.2 Vabiotech Description and Business Overview
6.6.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vabiotech Oral Live Cholera Vaccines Product Portfolio
6.6.5 Vabiotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Live Cholera Vaccines Industry Chain Analysis
7.2 Oral Live Cholera Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Live Cholera Vaccines Production Mode & Process Analysis
7.4 Oral Live Cholera Vaccines Sales and Marketing
7.4.1 Oral Live Cholera Vaccines Sales Channels
7.4.2 Oral Live Cholera Vaccines Distributors
7.5 Oral Live Cholera Vaccines Customer Analysis
8 Oral Live Cholera Vaccines Market Dynamics
8.1 Oral Live Cholera Vaccines Industry Trends
8.2 Oral Live Cholera Vaccines Market Drivers
8.3 Oral Live Cholera Vaccines Market Challenges
8.4 Oral Live Cholera Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Oral Live Cholera Vaccines by Type
1.2.1 Global Oral Live Cholera Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Euvichol- Plus
1.2.3 DUKORAL
1.2.4 Shanchol
1.2.5 Others
1.3 Oral Live Cholera Vaccines by Application
1.3.1 Global Oral Live Cholera Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Prevention
1.3.3 Emergency Response
1.4 Global Oral Live Cholera Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Live Cholera Vaccines Revenue 2020-2031
1.4.2 Global Oral Live Cholera Vaccines Sales 2020-2031
1.4.3 Global Oral Live Cholera Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oral Live Cholera Vaccines Market Competition by Manufacturers
2.1 Global Oral Live Cholera Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oral Live Cholera Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oral Live Cholera Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oral Live Cholera Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Live Cholera Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Live Cholera Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Oral Live Cholera Vaccines, Date of Enter into This Industry
2.8 Global Oral Live Cholera Vaccines Market Competitive Situation and Trends
2.8.1 Global Oral Live Cholera Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Live Cholera Vaccines Players Market Share by Revenue
2.8.3 Global Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Live Cholera Vaccines Market Scenario by Region
3.1 Global Oral Live Cholera Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oral Live Cholera Vaccines Sales by Region: 2020-2031
3.2.1 Global Oral Live Cholera Vaccines Sales by Region: 2020-2025
3.2.2 Global Oral Live Cholera Vaccines Sales by Region: 2026-2031
3.3 Global Oral Live Cholera Vaccines Revenue by Region: 2020-2031
3.3.1 Global Oral Live Cholera Vaccines Revenue by Region: 2020-2025
3.3.2 Global Oral Live Cholera Vaccines Revenue by Region: 2026-2031
3.4 North America Oral Live Cholera Vaccines Market Facts & Figures by Country
3.4.1 North America Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.4.3 North America Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Oral Live Cholera Vaccines Market Facts & Figures by Country
3.5.1 Europe Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.5.3 Europe Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Live Cholera Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Live Cholera Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oral Live Cholera Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Live Cholera Vaccines Market Facts & Figures by Country
3.7.1 Latin America Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Live Cholera Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Live Cholera Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Live Cholera Vaccines Sales by Type (2020-2031)
4.1.1 Global Oral Live Cholera Vaccines Sales by Type (2020-2025)
4.1.2 Global Oral Live Cholera Vaccines Sales by Type (2026-2031)
4.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Oral Live Cholera Vaccines Revenue by Type (2020-2031)
4.2.1 Global Oral Live Cholera Vaccines Revenue by Type (2020-2025)
4.2.2 Global Oral Live Cholera Vaccines Revenue by Type (2026-2031)
4.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Oral Live Cholera Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oral Live Cholera Vaccines Sales by Application (2020-2031)
5.1.1 Global Oral Live Cholera Vaccines Sales by Application (2020-2025)
5.1.2 Global Oral Live Cholera Vaccines Sales by Application (2026-2031)
5.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Oral Live Cholera Vaccines Revenue by Application (2020-2031)
5.2.1 Global Oral Live Cholera Vaccines Revenue by Application (2020-2025)
5.2.2 Global Oral Live Cholera Vaccines Revenue by Application (2026-2031)
5.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Oral Live Cholera Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PaxVax
6.1.1 PaxVax Company Information
6.1.2 PaxVax Description and Business Overview
6.1.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PaxVax Oral Live Cholera Vaccines Product Portfolio
6.1.5 PaxVax Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Oral Live Cholera Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Valneva
6.3.1 Valneva Company Information
6.3.2 Valneva Description and Business Overview
6.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Valneva Oral Live Cholera Vaccines Product Portfolio
6.3.5 Valneva Recent Developments/Updates
6.4 EuBiologics
6.4.1 EuBiologics Company Information
6.4.2 EuBiologics Description and Business Overview
6.4.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 EuBiologics Oral Live Cholera Vaccines Product Portfolio
6.4.5 EuBiologics Recent Developments/Updates
6.5 Shanghai United Cell Biotechnology
6.5.1 Shanghai United Cell Biotechnology Company Information
6.5.2 Shanghai United Cell Biotechnology Description and Business Overview
6.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolio
6.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
6.6 Vabiotech
6.6.1 Vabiotech Company Information
6.6.2 Vabiotech Description and Business Overview
6.6.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vabiotech Oral Live Cholera Vaccines Product Portfolio
6.6.5 Vabiotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Live Cholera Vaccines Industry Chain Analysis
7.2 Oral Live Cholera Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Live Cholera Vaccines Production Mode & Process Analysis
7.4 Oral Live Cholera Vaccines Sales and Marketing
7.4.1 Oral Live Cholera Vaccines Sales Channels
7.4.2 Oral Live Cholera Vaccines Distributors
7.5 Oral Live Cholera Vaccines Customer Analysis
8 Oral Live Cholera Vaccines Market Dynamics
8.1 Oral Live Cholera Vaccines Industry Trends
8.2 Oral Live Cholera Vaccines Market Drivers
8.3 Oral Live Cholera Vaccines Market Challenges
8.4 Oral Live Cholera Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Oral Live Cholera Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oral Live Cholera Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oral Live Cholera Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oral Live Cholera Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oral Live Cholera Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oral Live Cholera Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oral Live Cholera Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oral Live Cholera Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Live Cholera Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Live Cholera Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Oral Live Cholera Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Live Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Live Cholera Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Live Cholera Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oral Live Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Oral Live Cholera Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Oral Live Cholera Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Oral Live Cholera Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Oral Live Cholera Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oral Live Cholera Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Oral Live Cholera Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oral Live Cholera Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oral Live Cholera Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oral Live Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oral Live Cholera Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oral Live Cholera Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Oral Live Cholera Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Oral Live Cholera Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Oral Live Cholera Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Oral Live Cholera Vaccines Price (USD/Unit) by Type (2020-2025)
Table 59. Global Oral Live Cholera Vaccines Price (USD/Unit) by Type (2026-2031)
Table 60. Global Oral Live Cholera Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Oral Live Cholera Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Oral Live Cholera Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Oral Live Cholera Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Oral Live Cholera Vaccines Price (USD/Unit) by Application (2020-2025)
Table 69. Global Oral Live Cholera Vaccines Price (USD/Unit) by Application (2026-2031)
Table 70. PaxVax Company Information
Table 71. PaxVax Description and Business Overview
Table 72. PaxVax Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. PaxVax Oral Live Cholera Vaccines Product
Table 74. PaxVax Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Oral Live Cholera Vaccines Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Valneva Company Information
Table 81. Valneva Description and Business Overview
Table 82. Valneva Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Valneva Oral Live Cholera Vaccines Product
Table 84. Valneva Recent Developments/Updates
Table 85. EuBiologics Company Information
Table 86. EuBiologics Description and Business Overview
Table 87. EuBiologics Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. EuBiologics Oral Live Cholera Vaccines Product
Table 89. EuBiologics Recent Developments/Updates
Table 90. Shanghai United Cell Biotechnology Company Information
Table 91. Shanghai United Cell Biotechnology Description and Business Overview
Table 92. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product
Table 94. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 95. Vabiotech Company Information
Table 96. Vabiotech Description and Business Overview
Table 97. Vabiotech Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Vabiotech Oral Live Cholera Vaccines Product
Table 99. Vabiotech Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Oral Live Cholera Vaccines Distributors List
Table 103. Oral Live Cholera Vaccines Customers List
Table 104. Oral Live Cholera Vaccines Market Trends
Table 105. Oral Live Cholera Vaccines Market Drivers
Table 106. Oral Live Cholera Vaccines Market Challenges
Table 107. Oral Live Cholera Vaccines Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Live Cholera Vaccines
Figure 2. Global Oral Live Cholera Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Live Cholera Vaccines Market Share by Type: 2024 & 2031
Figure 4. Euvichol- Plus Product Picture
Figure 5. DUKORAL Product Picture
Figure 6. Shanchol Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oral Live Cholera Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral Live Cholera Vaccines Market Share by Application: 2024 & 2031
Figure 10. Prevention
Figure 11. Emergency Response
Figure 12. Global Oral Live Cholera Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Oral Live Cholera Vaccines Market Size (2020-2031) & (US$ Million)
Figure 14. Global Oral Live Cholera Vaccines Sales (2020-2031) & (K Units)
Figure 15. Global Oral Live Cholera Vaccines Average Price (USD/Unit) & (2020-2031)
Figure 16. Oral Live Cholera Vaccines Report Years Considered
Figure 17. Oral Live Cholera Vaccines Sales Share by Manufacturers in 2024
Figure 18. Global Oral Live Cholera Vaccines Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Oral Live Cholera Vaccines Players: Market Share by Revenue in Oral Live Cholera Vaccines in 2024
Figure 20. Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Oral Live Cholera Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 23. North America Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 24. the United States Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 27. Europe Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 28. Germany Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. UK Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Oral Live Cholera Vaccines Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Oral Live Cholera Vaccines Revenue Market Share by Region (2020-2031)
Figure 35. China Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 45. Latin America Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Oral Live Cholera Vaccines by Type (2020-2031)
Figure 55. Global Revenue Market Share of Oral Live Cholera Vaccines by Type (2020-2031)
Figure 56. Global Oral Live Cholera Vaccines Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Oral Live Cholera Vaccines by Application (2020-2031)
Figure 58. Global Revenue Market Share of Oral Live Cholera Vaccines by Application (2020-2031)
Figure 59. Global Oral Live Cholera Vaccines Price (USD/Unit) by Application (2020-2031)
Figure 60. Oral Live Cholera Vaccines Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Oral Live Cholera Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oral Live Cholera Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oral Live Cholera Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oral Live Cholera Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oral Live Cholera Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oral Live Cholera Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oral Live Cholera Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oral Live Cholera Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Live Cholera Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Live Cholera Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Oral Live Cholera Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Live Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Live Cholera Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Live Cholera Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oral Live Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Oral Live Cholera Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Oral Live Cholera Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Oral Live Cholera Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Oral Live Cholera Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oral Live Cholera Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Oral Live Cholera Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oral Live Cholera Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oral Live Cholera Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oral Live Cholera Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oral Live Cholera Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oral Live Cholera Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Oral Live Cholera Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Oral Live Cholera Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Oral Live Cholera Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Oral Live Cholera Vaccines Price (USD/Unit) by Type (2020-2025)
Table 59. Global Oral Live Cholera Vaccines Price (USD/Unit) by Type (2026-2031)
Table 60. Global Oral Live Cholera Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Oral Live Cholera Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Oral Live Cholera Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Oral Live Cholera Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oral Live Cholera Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Oral Live Cholera Vaccines Price (USD/Unit) by Application (2020-2025)
Table 69. Global Oral Live Cholera Vaccines Price (USD/Unit) by Application (2026-2031)
Table 70. PaxVax Company Information
Table 71. PaxVax Description and Business Overview
Table 72. PaxVax Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. PaxVax Oral Live Cholera Vaccines Product
Table 74. PaxVax Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Oral Live Cholera Vaccines Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Valneva Company Information
Table 81. Valneva Description and Business Overview
Table 82. Valneva Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Valneva Oral Live Cholera Vaccines Product
Table 84. Valneva Recent Developments/Updates
Table 85. EuBiologics Company Information
Table 86. EuBiologics Description and Business Overview
Table 87. EuBiologics Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. EuBiologics Oral Live Cholera Vaccines Product
Table 89. EuBiologics Recent Developments/Updates
Table 90. Shanghai United Cell Biotechnology Company Information
Table 91. Shanghai United Cell Biotechnology Description and Business Overview
Table 92. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product
Table 94. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 95. Vabiotech Company Information
Table 96. Vabiotech Description and Business Overview
Table 97. Vabiotech Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Vabiotech Oral Live Cholera Vaccines Product
Table 99. Vabiotech Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Oral Live Cholera Vaccines Distributors List
Table 103. Oral Live Cholera Vaccines Customers List
Table 104. Oral Live Cholera Vaccines Market Trends
Table 105. Oral Live Cholera Vaccines Market Drivers
Table 106. Oral Live Cholera Vaccines Market Challenges
Table 107. Oral Live Cholera Vaccines Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Live Cholera Vaccines
Figure 2. Global Oral Live Cholera Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Live Cholera Vaccines Market Share by Type: 2024 & 2031
Figure 4. Euvichol- Plus Product Picture
Figure 5. DUKORAL Product Picture
Figure 6. Shanchol Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oral Live Cholera Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral Live Cholera Vaccines Market Share by Application: 2024 & 2031
Figure 10. Prevention
Figure 11. Emergency Response
Figure 12. Global Oral Live Cholera Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Oral Live Cholera Vaccines Market Size (2020-2031) & (US$ Million)
Figure 14. Global Oral Live Cholera Vaccines Sales (2020-2031) & (K Units)
Figure 15. Global Oral Live Cholera Vaccines Average Price (USD/Unit) & (2020-2031)
Figure 16. Oral Live Cholera Vaccines Report Years Considered
Figure 17. Oral Live Cholera Vaccines Sales Share by Manufacturers in 2024
Figure 18. Global Oral Live Cholera Vaccines Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Oral Live Cholera Vaccines Players: Market Share by Revenue in Oral Live Cholera Vaccines in 2024
Figure 20. Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Oral Live Cholera Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 23. North America Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 24. the United States Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 27. Europe Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 28. Germany Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. UK Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Oral Live Cholera Vaccines Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Oral Live Cholera Vaccines Revenue Market Share by Region (2020-2031)
Figure 35. China Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 45. Latin America Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Oral Live Cholera Vaccines Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Oral Live Cholera Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Oral Live Cholera Vaccines by Type (2020-2031)
Figure 55. Global Revenue Market Share of Oral Live Cholera Vaccines by Type (2020-2031)
Figure 56. Global Oral Live Cholera Vaccines Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Oral Live Cholera Vaccines by Application (2020-2031)
Figure 58. Global Revenue Market Share of Oral Live Cholera Vaccines by Application (2020-2031)
Figure 59. Global Oral Live Cholera Vaccines Price (USD/Unit) by Application (2020-2031)
Figure 60. Oral Live Cholera Vaccines Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232